Trial intelligence / Profile preview

Oxytocin vs hCG as Ovulation Trigger in PCOS

NCT06725004Phase 3Completed

Start
Jan 2023
Primary completion
Dec 2023
Modality
Peptides
Countries
1
01

Overview

A Phase 3 trial of oxytocin in polycystic ovary syndrome (PCOS). Started Jan 2023; status: completed.

02

Drugs

oxytocin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT06725004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06725004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call